Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - March 2013


Controlled Release

18 Mar 2013 - 19 Mar 2013 - London, UK



Bookmark and Share


SMi presents its 10th annual conference on . . .

Controlled Release – the only conference in Europe to focus specifically on controlled release.

At this well-established annual event you will hear, from the global expert speaking faculty, how controlled release products and drugs have developed over the past 12 months.  

ATTEND TO:

• Discover the very latest developments in this innovative and booming industry

• New for 2013:

- Investigating structure-activity relationships of siRNA nanoparticles

- Challenges of pre-clinical gastro-retentive dosage form development

- Numerous case studies from big pharma laboratories – such as GSKs formulation development programme

• Benefit from an interactive half-day post-conference workshop on SMART formulation design: tools and strategies for complex formulation design and problem solving

KEY SPEAKERS INCLUDE:

Michael Keller, PDU Parenteral, Topical & siRNA Lead, Novartis

Andy Lewis, Director, Ipsen

Petra Wicklandt, CMC Development, Merck

Howard Stevens, Professor, Exploratory Drug Discovery, University of Strathclyde

David Elder, Externalisation Director, GlaxoSmithKline

Monica Rosa, Director, SigmoidPharma

Navnit Shah, Distinguished Scientist, Roche

Mark Wilson, Director, Collaboration Management, GlaxoSmithKline

Dmitry Samarsky, Technology & Business Development, Ribobio

Richard Elkes, Senior Research Scientist, Merck 

and many more . . .

Click here for the programme, full speaker line-up and to register http://www.smi-online.co.uk/goto/controlledrelease27.asp 



Further information
Scientific News
Experimental MERS Vaccine Shows Promise in Animal Studies
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines.
Young South African Women can Adhere to Daily PrEP Regimen as HIV Prevention
NIH-funded study finds men in Bangkok, Harlem also successful in taking daily dose.
Researchers Find Key Player in Diabetic Kidney Disease Through Power of Metabolomics
Discovery could lead to new and better diagnostic marker for chronic kidney disease.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Santhera Announces First Patient Dosing with Omigapil in CMD
Company announces full patient recruitment of CALLISTO study.
Study Shows Promise of Precision Medicine for Most Common Type of Lymphoma
The study appeared online July 20, 2015, in Nature Medicine.
HIV Control Through Treatment Durably Prevents Heterosexual Transmission of Virus
NIH-funded trial proves suppressive antiretroviral therapy for HIV-infected people effective in protecting uninfected partners.
Adaptimmune's Novel Cancer Therapeutics Show Positive Clinical Trial Results
The company has announced that positive data from its Phase I/II study of its affinity enhanced T-cell receptor (TCR) therapeutic targeting the NY-ESO-1 cancer antigen in patients with multiple myeloma has been published.
Early Antiretroviral Therapy Prevents Non-AIDS Outcomes in HIV-infected People
NIH-supported findings illustrate manifold benefit of therapy.
Adaptimmune’s NY-ESO-1 TCR-engineered T-Cells Demonstrate Durable Persistence
Study has been published in Nature Medicine.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!